General MedicationsORALGeneric

DULOXETINE HYDROCHLORIDE

Standard Dose

EQ 30MG BASE

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview DULOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 090669 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient DULOXETINE HYDROCHLORIDE Form and strength CAPSULE, DELAYED RELEASE; ORAL - EQ 30MG BASE Sponsor IMPAX LABS INC Submission history Latest submission status date: 2010-11-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview DULOXETINE HYDROCHLORIDE is listed in Drugs@FDA under application 090669 (ANDA). Marketing status: None (Tentative Approval) Active ingredient DULOXETINE HYDROCHLORIDE Form and strength CAPSULE, DELAYED RELEASE; ORAL - EQ 30MG BASE Sponsor IMPAX LABS INC Submission history Latest submission status date: 2010-11-18 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.